# Filing Detail

Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001213900-25-106708
Filing Date
2025-11-05
Accepted
2025-11-05 17:03:42
Documents
1
Period of Report
2024-12-31
Effectiveness Date
2025-11-05

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | ARS | ea0260530-03.pdf | ARS | 985521
| Complete submission text file | 0001213900-25-106708.txt |  | 1344765

Mailing Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017
Business Address 100 PARK AVE., 23RD FLOOR NEW YORK NY 10017 (646) 677-3870
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

EIN.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-36374 | Film No.: 251454985
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)